UTZ vs MED
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 12, 2026
UTZ
MED
Investment Advisor Scores
MED
AI Analyst Insights
Detailed Metrics Comparison
| Metric | UTZ | MED | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 17.331 | 12.4844 | MED |
| PEG Ratio | 0 | 0.972 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 1.4% | -27.6% | UTZ |
| Earnings Growth | -47.8% | -87.2% | UTZ |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.6/100 | 42.7/100 | UTZ |
| Profit Margin | -2.0% | -8.1% | UTZ |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
UTZ
MarkupPrice above SMA50, rising 50-day trend (28.4% over 20 days), RSI 80
MED
MarkupPrice above SMA50, rising 50-day trend (2.4% over 20 days), RSI 53
Fundamentals Snapshot
| Metric | UTZ | MED |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 17.1 | -43.0 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.3% |
| Gross Margin | 0.3% | 0.7% |
| Operating Margin | 0.0% | -0.1% |
| EPS | -0.33 | -2.31 |
| Dividend Yield | 0.03% | — |